- As One Spouse’s Blood Pressure Rises, So Does the Other’s: Study
- Folks at High Risk of Heart Disease May Gain From Eating Mackerel, Tuna
- Minorities Expect and Prepare for Unfair Health Care, Survey Shows
- Women Need Better Guidance on Exercise & the Menstrual Cycle, Study Shows
- State Abortion Bans Have New Doctors Staying Away
- Mind, Body Symptoms Can Precede MS Diagnosis for Years
- Starting Periods Early Linked to Higher Odds for Diabetes, Stroke
- Spotting Epilepsy in Kids Isn’t Always Easy: Know the Signs
- New Syndrome May Be Affecting Babies Exposed to Fentanyl
- Wasabi Shows Memory-Boosting Powers in Study
Imbruvica Approved for Mantle Cell Lymphoma
WEDNESDAY, Nov. 13Imbruvica (ibrutinib) has been approved by the U.S. Food and Drug Administration to treat mantle cell lymphoma (MCL), a rare but aggressive form of blood cancer.
MCL represents about six percent of non-Hodgkin lymphoma cases, the agency said Wednesday in a news release. By the time it’s usually diagnosed, it has spread to other areas such as the lymph nodes or bone marow.
Imbruvica, designed to inhibit an enzyme that cancer cells need to spread, was granted the FDA’s rare “breakthrough therapy” status as a drug that promises to offer a “substantial improvement over available therapies for patients with serious or life-threatening diseases,” the agency said.
Imbruvica was evaluated in a study of 111 participants. Of those who took the drug daily, 66 percent had their cancer shrink or disappear, the FDA said. The most common side effects included: low blood platelets, diarrhea, low white blood cells, anemia, fatigue, musculoskeletal pain, swelling and upper respiratory infection.
Imbruvica is co-marketed by Sunnyvale, Calif.-based Pharmacyclics, and Raritan, N.J.-based Janssen Biotech.
More information
To learn more about non-Hodgkin lymphoma, visit Medline Plus.
Source: HealthDay
Copyright © 2023 HealthDay. All rights reserved.
Related
-
Starting Periods Early Linked to Higher Odds for Diabetes, StrokeGirls whose periods begin before the age of 13...
- December 6, 2023
-
Timing of Menopause Could Affect a Woman’s Muscle LossWomen who enter menopause early could be at increased...
- December 4, 2023
-
‘Couch Potato’ Lifestyle Could Raise Women’s Odds for FibroidsWomen in a Chinese study who sat for more...
- November 30, 2023
-
More Evidence That Regular Mammograms Save LivesA woman who gets her regular mammograms as scheduled...
- November 30, 2023
